Close
ACHEMA MIDDLE EAST 2026

Sun Seals Ranbaxy Deal, To Invest $300 MN in R&D

Sun Pharmaceutical Industries, India’s largest drugmaker, on Wednesday announced the closure of its merger with Ranbaxy Laboratories and said the integration would deliver synergies...

We would like to make one plus one more than two: Uday Baldota

Sun Pharmaceutical Industries is in the process of closing its merger with Ranbaxy. The former's chief financial officer (CFO), Uday Baldota, talks to Digbijay...

Sun Pharmaceutical wins US approval to buy Ranbaxy

Sun Pharmaceutical Industries LtdBSE -0.35 % has won US approval to buy Ranbaxy Laboratories LtdBSE -0.61 % on condition that it sell its interest...

Collegium Provides Update on FDA Review of Xtampza ER, an Abuse-Deterrent Analgesic for the Treatment of Chronic Pain

Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) has advised Collegium that it will not be able to...

Drugs Used in Cancer, Arthritis May Help Fight Hair Loss

one approved for use in arthritis and the other approved for cancer -- may also hold potential for boosting hair growth, new animal research...

Allergan to Present New Data for VIBERZI™ (eluxadoline) at the American College of Gastroenterology 2015 Annual Scientific Meeting

Allergan plc today announced that three data posters/presentations for eluxadoline will be presented during the American College of Gastroenterology 2015 Annual Scientific Meeting in...

Allergan Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE® Gel Drops

In a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage a leading global pharmaceutical company, today announced...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...